Tandem Diabetes Care reports a 2Q growth of $222 million in 2024 By Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:), a leading medical device company, has reported a significant second-quarter sales growth of $222 million...
Tandem Diabetes Care, Inc. (NASDAQ:), a leading medical device company, has reported a significant second-quarter sales growth of $222 million...
The inquest that begins Monday into the death seven years ago of a First Nations woman in northwestern Ontario is expected...
Most people have heard of type 1 diabetes, a chronic condition in which the pancreas makes too little or no...
A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity...
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom's G7 and G6 continuous...
As marijuana loses much of its stigma and laws around its use relax, Americans are increasingly consuming it medically and...